0000899243-22-012857.txt : 20220330 0000899243-22-012857.hdr.sgml : 20220330 20220330203228 ACCESSION NUMBER: 0000899243-22-012857 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220330 FILED AS OF DATE: 20220330 DATE AS OF CHANGE: 20220330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vukovic Vojo CENTRAL INDEX KEY: 0001466794 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 22788674 MAIL ADDRESS: STREET 1: C/O SYNTA PHARMACEUTICALS CORP. STREET 2: 45 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 285 SUMMER STREET STREET 2: UNIT 101 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 285 SUMMER STREET STREET 2: UNIT 101 CITY: BOSTON STATE: MA ZIP: 02210 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-03-30 2022-03-24 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001466794 Vukovic Vojo C/O AILERON THERAPEUTICS, INC. 285 SUMMER STREET, SUITE 101 BOSTON MA 02210 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 0.48 2022-03-30 4 A 0 150000 0.00 A 2032-03-29 Common Stock 150000 150000 D This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022. The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026. /s/ Richard Wanstall, attorney-in-fact for Vojo Vukovic 2022-03-30